Stockwatch: Casualties From The War On Inversions

In a surprise move last week, the US Treasury signalled its capacity to prevent any further inversion transactions and, with the public endorsement by President Obama, ended the proposed merger of Pfizer, Inc. and Allergan Plc that would have seen Pfizer relocate its tax jurisdiction to Ireland and access much of its offshore cash without a tax penalty.